YBX1 and lung adenocarcinoma: What’s more, it has been suggested that Y-box binding protein-1 (YB-1) may be involved in the drug resistance of cisplatin (25), paclitaxel (26), and Adriamycin (27), indicating that Linc00665 can promote the growth of lung adenocarcinoma by interacting with YB-1 (28).